ENTX

ENTX

USD

Entera Bio Ltd. Ordinary Shares

$2.100-0.090 (-4.110%)

Real-time Price

Healthcare
Biotechnology
Israel

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$2.190

High

$2.280

Low

$2.040

Volume

0.05M

Company Fundamentals

Market Cap

95.4M

Industry

Biotechnology

Country

Israel

Trading Stats

Avg Volume

0.04M

Exchange

NCM

Currency

USD

52-Week Range

Low $1.41Current $2.100High $2.79

Related News

GlobeNewswire

Entera Bio's EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO

JERUSALEM, April 15, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX), a leader in the development of oral peptides and proteins replacement therapies, announced highlights from Dr. Rachel B Wagman's oral

View more
Entera Bio's EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO
GlobeNewswire

Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates

JERUSALEM, March 28, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and key business

View more
Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates